`

VelaVigo

Biotechnology Research

Specialities :
Biologics drug discovery and development
Adc
New modalities
And bispecific/multi-specific antibodies
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About VelaVigo

What does Velavigo do?+

VelaVigo was founded by Dr. Jing Li, a renowned biopharma executive, in October 2021. We leverage discovery as an innovative engine with an emphasis on novel technologies, including bispecific/multi-specific antibodies, ADC, and new modalities. We are committed to building full capabilities covering the entire value chain of drug discovery and development, including novel discovery technology platform, translational medicine, CMC, clinical development and commercialization. VelaVigo is building its global R&D headquarter in Shanghai, and will set up R&D footprint globally. VelaVigo combines internal discovery/development and win-win partnership to drive its portfolio. We strive to the development of innovative, affordable biological drugs...

What are Velavigo's specialties? +

Biologics drug discovery and development,adc,new modalities,and bispecific/multi-specific antibodies

What is Velavigo's industry? +

Velavigo operates in the Biotechnology research industry.

What is Velavigo's revenue? +

Velavigo's revenue is 11m - 100m

What is Velavigo's company size? +

Velavigo has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.